Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Propagation of Uncertainty from Systematic Error01:10

Propagation of Uncertainty from Systematic Error

The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this particular...
Uncertainty: Overview00:59

Uncertainty: Overview

In analytical chemistry, we often perform repetitive measurements to detect and minimize inaccuracies caused by both determinate and indeterminate errors. Despite the cares we take, the presence of random errors means that repeated measurements almost never have exactly the same magnitude. The collective difference between these measurements - observed values - and the estimated or expected value is called uncertainty. Uncertainty is conventionally written after the estimated or expected value.
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Research on the detection algorithm of electrocardiogram characteristic wave based on energy segmentation and stationary wavelet transform].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2021
Same author

Novel Partial Exon 51 Deletion in the Duchenne Muscular Dystrophy Gene Identified <i>via</i> Whole Exome Sequencing and Long-Read Whole-Genome Sequencing.

Frontiers in genetics·2021
Same author

Suppressed farnesoid X receptor by iron overload in mice and humans potentiates iron-induced hepatotoxicity.

Hepatology (Baltimore, Md.)·2021
Same author

Taohong Siwu-Containing Serum Enhances Angiogenesis in Rat Aortic Endothelial Cells by Regulating the VHL/HIF-1<i>α</i>/VEGF Signaling Pathway.

Evidence-based complementary and alternative medicine : eCAM·2021
Same author

Surgical radiofrequency ablation of atrial flutter: which operation should we choose?

Journal of surgical case reports·2021
Same author

Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma.

Translational andrology and urology·2021

Related Experiment Video

Updated: May 10, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

The Impact of Model Uncertainty on Benchmark Dose Estimation.

R Webster West1, Walter W Piegorsch, Edsel A Peña

  • 1Department of Statistics, Texas A&M University, College Station, TX, USA.

Environmetrics
|June 25, 2013
PubMed
Summary

Model misspecification in toxicological risk assessment can lead to inaccurate benchmark dose (BMD) and benchmark dose lower confidence limit (BMDL) calculations. This may result in unsafe low-dose inferences, potentially exceeding target risk levels.

Keywords:
AICBMDLBenchmark analysisExcess RiskExtraModel adequacyModel selectionQuantitative risk assessmentRisk

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ &alpha; and &beta; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: May 10, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Irradiator Commissioning and Dosimetry for Assessment of LQ &alpha; and &beta; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

  • Toxicological Risk Assessment
  • Biostatistics
  • Environmental Health

Background:

  • The benchmark dose (BMD) approach is crucial for estimating low exposure levels in toxicological risk assessment.
  • Traditional methods rely on parametric dose-response models, but model specification and selection introduce uncertainty.
  • Model misspecification can lead to inaccurate low-dose inferences and potentially unsafe risk assessments.

Purpose of the Study:

  • To investigate the impact of model selection and misspecification on BMD and BMDL estimations.
  • To evaluate the associated extra risks at BMDL values under different model scenarios.
  • To highlight potential dangers in traditional model selection strategies for BMD calculations.

Main Methods:

  • Large-scale Monte Carlo simulations were employed to study dose-response experiments with quantal data.
  • The study focused on the effects of parametric model misspecification on BMD and BMDL.
  • Analysis included the extra risks achieved at BMDL under correctly and incorrectly selected models.

Main Results:

  • A significant percentage of simulations showed that the true extra risk at the BMDL exceeded the benchmark risk (BMR) when models were misspecified.
  • Incorrect model selection can lead to unreliable BMDL values and underestimation of actual risks.
  • The study identified potential safety concerns arising from standard model selection practices.

Conclusions:

  • Traditional model selection strategies in BMD analysis can be hazardous.
  • Model misspecification poses a substantial risk to the accuracy and safety of low-dose risk assessments.
  • Careful consideration and robust methods for model selection are essential for reliable toxicological risk assessment.